Dr. Alfonso Annunziata

Dr. Alfonso Annunziata earned his Bachelor's and Master's degrees at the University of Napoli Federico II, where he worked in the Organometallic Chemistry Group under the mentorship of Prof. Francesco Ruffo and Dr. Maria Elena Cucciolito. In 2018, he began his doctoral studies within the same group, focusing on the development of novel glycoconjugate metal complexes as potential anticancer agents. During his PhD, he completed a six-month research placement at EPFL, Lausanne, in the group led by Prof. Paul Dyson.  

After obtaining his PhD in 2022, he joined the IPCM at Sorbonne University, Paris, as a postdoctoral researcher, where he worked on organometallic iridium complexes for cancer treatment and imaging applications, under the supervision of Dr. Michele Salmain. He then relocated to Spain to join Dr. Mónica Pérez Temprano’s group at ICIQ, Tarragona, where he explored the organometallic chemistry and mechanisms of cobalt-mediated C-H functionalization reactions.
In 2023, Alfonso was awarded a Marie Skłodowska-Curie Postdoctoral Fellowship to join Dr. Ana Pizarro's group at IMDEA Nanociencia. His research focuses on the development of new cobalt complexes as molecular tools to modulate human cell redox homeostasis.

This email address is being protected from spambots. You need JavaScript enabled to view it.